{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:55:23Z","timestamp":1794970523031,"version":"4.9.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fibroblast activation protein (Fap) is a serine protease that degrades denatured type I collagen, \u03b12-antiplasmin and FGF21. Fap is highly expressed in bone marrow stromal cells and functions as an osteogenic suppressor and can be inhibited by the bone growth factor Osteolectin (Oln). Fap is also expressed in synovial fibroblasts and positively correlated with the severity of rheumatoid arthritis (RA). However, whether Fap plays a critical role in osteoarthritis (OA) remains poorly understood. Here, we found that Fap is significantly elevated in osteoarthritic synovium, while the genetic deletion or pharmacological inhibition of Fap significantly ameliorated posttraumatic OA in mice. Mechanistically, we found that Fap degrades denatured type II collagen (Col II) and Mmp13-cleaved native Col II. Intra-articular injection of rFap significantly accelerated Col II degradation and OA progression. In contrast, Oln is expressed in the superficial layer of articular cartilage and is significantly downregulated in OA. Genetic deletion of Oln significantly exacerbated OA progression, which was partially rescued by Fap deletion or inhibition. Intra-articular injection of rOln significantly ameliorated OA progression. Taken together, these findings identify Fap as a critical pathogenic factor in OA that could be targeted by both synthetic and endogenous inhibitors to ameliorate articular cartilage degradation.<\/jats:p>","DOI":"10.1038\/s41413-022-00243-8","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T03:02:38Z","timestamp":1672628558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Inhibition of fibroblast activation protein ameliorates cartilage matrix degradation and osteoarthritis progression"],"prefix":"10.1038","volume":"11","author":[{"given":"Aoyuan","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genbin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiya","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqiu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3401-369X","authenticated-orcid":false,"given":"Rui","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,2]]},"reference":[{"key":"243_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/annrheumdis-2019-216515","volume":"79","author":"S Safiri","year":"2020","unstructured":"Safiri, S. et al. Global, regional and national burden of osteoarthritis 1990\u20132017: a systematic analysis of the global burden of disease study 2017. Ann. Rheum. Dis. 79, 819\u2013828 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"243_CR2","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(11)60243-2","volume":"377","author":"JW Bijlsma","year":"2011","unstructured":"Bijlsma, J. W., Berenbaum, F. & Lafeber, F. P. Osteoarthritis: an update with relevance for clinical practice. Lancet (Lond., Engl.) 377, 2115\u20132126 (2011).","journal-title":"Lancet (Lond., Engl.)"},{"key":"243_CR3","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.joca.2014.07.015","volume":"22","author":"A Turkiewicz","year":"2014","unstructured":"Turkiewicz, A. et al. Current and future impact of osteoarthritis on health care: a population-based study with projections to year 2032. Osteoarthr. Cartil. 22, 1826\u20131832 (2014).","journal-title":"Osteoarthr. Cartil."},{"key":"243_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/03008207.2016.1177036","volume":"57","author":"Y Wei","year":"2016","unstructured":"Wei, Y. & Bai, L. Recent advances in the understanding of molecular mechanisms of cartilage degeneration, synovitis and subchondral bone changes in osteoarthritis. Connect. Tissue Res. 57, 245\u2013261 (2016).","journal-title":"Connect. Tissue Res."},{"key":"243_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.joca.2006.11.006","volume":"15","author":"PM van der Kraan","year":"2007","unstructured":"van der Kraan, P. M. & van den Berg, W. B. Osteophytes: relevance and biology. Osteoarthr. Cartil. 15, 237\u2013244 (2007).","journal-title":"Osteoarthr. Cartil."},{"key":"243_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","volume":"12","author":"WH Robinson","year":"2016","unstructured":"Robinson, W. H. et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 12, 580\u2013592 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"243_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41413-021-00147-z","volume":"9","author":"Y Hu","year":"2021","unstructured":"Hu, Y., Chen, X., Wang, S., Jing, Y. & Su, J. Subchondral bone microenvironment in osteoarthritis and pain. Bone Res. 9, 20 (2021).","journal-title":"Bone Res."},{"key":"243_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.tips.2014.03.005","volume":"35","author":"G Zhen","year":"2014","unstructured":"Zhen, G. & Cao, X. Targeting TGFbeta signaling in subchondral bone and articular cartilage homeostasis. Trends Pharm. Sci. 35, 227\u2013236 (2014).","journal-title":"Trends Pharm. Sci."},{"key":"243_CR9","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrrheum.2015.95","volume":"11","author":"T Pap","year":"2015","unstructured":"Pap, T. & Korb-Pap, A. Cartilage damage in osteoarthritis and rheumatoid arthritis-two unequal siblings. Nat. Rev. Rheumatol. 11, 606\u2013615 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"243_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","volume":"7","author":"M Kapoor","year":"2011","unstructured":"Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J. P. & Fahmi, H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 7, 33\u201342 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"243_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bbapap.2011.06.020","volume":"1824","author":"L Troeberg","year":"2012","unstructured":"Troeberg, L. & Nagase, H. Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim. Biophys. Acta 1824, 133\u2013145 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"243_CR12","first-page":"Cd010675","volume":"9","author":"GC Gracitelli","year":"2016","unstructured":"Gracitelli, G. C., Moraes, V. Y., Franciozi, C. E., Luzo, M. V. & Belloti, J. C. Surgical interventions (microfracture, drilling, mosaicplasty, and allograft transplantation) for treating isolated cartilage defects of the knee in adults. Cochrane Database Syst. Rev. 9, Cd010675 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"243_CR13","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s00167-016-4047-8","volume":"24","author":"P Angele","year":"2016","unstructured":"Angele, P. et al. Chondral and osteochondral operative treatment in early osteoarthritis. Knee Surg. Sports Traumatol. Arthrosc. 24, 1743\u20131752 (2016).","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"243_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","volume":"386","author":"S Glyn-Jones","year":"2015","unstructured":"Glyn-Jones, S. et al. Osteoarthritis. Lancet (Lond., Engl.) 386, 376\u2013387 (2015).","journal-title":"Lancet (Lond., Engl.)"},{"key":"243_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/art.41142","volume":"72","author":"SL Kolasinski","year":"2020","unstructured":"Kolasinski, S. L. et al. 2019 American College of Rheumatology\/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 72, 220\u2013233 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"243_CR16","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","volume":"27","author":"RR Bannuru","year":"2019","unstructured":"Bannuru, R. R. et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr. Cartil. 27, 1578\u20131589 (2019).","journal-title":"Osteoarthr. Cartil."},{"key":"243_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.semarthrit.2019.04.008","volume":"49","author":"O Bruy\u00e8re","year":"2019","unstructured":"Bruy\u00e8re, O. et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin. Arthritis Rheum. 49, 337\u2013350 (2019).","journal-title":"Semin. Arthritis Rheum."},{"key":"243_CR18","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s00167-016-4089-y","volume":"24","author":"G Filardo","year":"2016","unstructured":"Filardo, G. et al. Non-surgical treatments for the management of early osteoarthritis. Knee Surg. Sports Traumatol. Arthrosc. 24, 1775\u20131785 (2016).","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"243_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nrrheum.2010.198","volume":"7","author":"D Heinegard","year":"2011","unstructured":"Heinegard, D. & Saxne, T. The role of the cartilage matrix in osteoarthritis. Nat. Rev. Rheumatol. 7, 50\u201356 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"243_CR20","first-page":"139","volume":"26","author":"J Bondeson","year":"2008","unstructured":"Bondeson, J., Wainwright, S., Hughes, C. & Caterson, B. The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review. Clin. Exp. Rheumatol. 26, 139\u2013145 (2008).","journal-title":"Clin. Exp. Rheumatol."},{"key":"243_CR21","doi-asserted-by":"publisher","first-page":"116786","DOI":"10.1016\/j.lfs.2019.116786","volume":"234","author":"EE Mehana","year":"2019","unstructured":"Mehana, E. E., Khafaga, A. F. & El-Blehi, S. S. The role of matrix metalloproteinases in osteoarthritis pathogenesis: an updated review. Life Sci. 234, 116786 (2019).","journal-title":"Life Sci."},{"key":"243_CR22","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1074\/jbc.271.3.1544","volume":"271","author":"V Knauper","year":"1996","unstructured":"Knauper, V., Lopez-Otin, C., Smith, B., Knight, G. & Murphy, G. Biochemical characterization of human collagenase-3. J. Biol. Chem. 271, 1544\u20131550 (1996).","journal-title":"J. Biol. Chem."},{"key":"243_CR23","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.2174\/0929867326666181217153118","volume":"27","author":"Y Wan","year":"2020","unstructured":"Wan, Y. et al. Selective MMP-13 inhibitors: promising agents for the therapy of osteoarthritis. Curr. Med Chem. 27, 3753\u20133769 (2020).","journal-title":"Curr. Med Chem."},{"key":"243_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/ar325","volume":"3","author":"JS Mort","year":"2001","unstructured":"Mort, J. S. & Billington, C. J. Articular cartilage and changes in arthritis: matrix degradation. Arthritis Res. 3, 337\u2013341 (2001).","journal-title":"Arthritis Res."},{"key":"243_CR25","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1172\/JCI118475","volume":"97","author":"PG Mitchell","year":"1996","unstructured":"Mitchell, P. G. et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Investig. 97, 761\u2013768 (1996).","journal-title":"J. Clin. Investig."},{"key":"243_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/bj2980403","volume":"298","author":"L B\u00e1nyai","year":"1994","unstructured":"B\u00e1nyai, L., Tordai, H. & Patthy, L. The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A). Biochem. J. 298, 403\u2013407 (1994).","journal-title":"Biochem. J."},{"key":"243_CR27","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1177\/00220345870660071201","volume":"66","author":"CM Overall","year":"1987","unstructured":"Overall, C. M. & Sodek, J. Initial characterization of a neutral metalloproteinase, active on native 3\/4-collagen fragments, synthesized by ROS 17\/2.8 osteoblastic cells, periodontal fibroblasts, and identified in gingival crevicular fluid. J. Dent. Res. 66, 1271\u20131282 (1987).","journal-title":"J. Dent. Res."},{"key":"243_CR28","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1002\/art.11030","volume":"48","author":"R Renkiewicz","year":"2003","unstructured":"Renkiewicz, R. et al. Broad-spectrum matrix metalloproteinase inhibitor marimastat-induced musculoskeletal side effects in rats. Arthritis Rheum. 48, 1742\u20131749 (2003).","journal-title":"Arthritis Rheum."},{"key":"243_CR29","doi-asserted-by":"publisher","first-page":"R109","DOI":"10.1186\/ar2315","volume":"9","author":"P Krzeski","year":"2007","unstructured":"Krzeski, P. et al. Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study. Arthritis Res. Ther. 9, R109 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"243_CR30","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1002\/art.24046","volume":"58","author":"JM Milner","year":"2008","unstructured":"Milner, J. M., Patel, A. & Rowan, A. D. Emerging roles of serine proteinases in tissue turnover in arthritis. Arthritis Rheum. 58, 3644\u20133656 (2008).","journal-title":"Arthritis Rheum."},{"key":"243_CR31","doi-asserted-by":"publisher","first-page":"407518","DOI":"10.1155\/2014\/407518","volume":"2014","author":"PY Chou","year":"2014","unstructured":"Chou, P. Y., Su, C. M., Huang, C. Y. & Tang, C. H. The characteristics of thrombin in osteoarthritic pathogenesis and treatment. Biomed. Res. Int. 2014, 407518 (2014).","journal-title":"Biomed. Res. Int."},{"key":"243_CR32","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/art.40133","volume":"69","author":"DJ Wilkinson","year":"2017","unstructured":"Wilkinson, D. J. et al. Matriptase induction of metalloproteinase-dependent aggrecanolysis in vitro and in vivo: promotion of osteoarthritic cartilage damage by multiple mechanisms. Arthritis Rheumatol. 69, 1601\u20131611 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"243_CR33","doi-asserted-by":"publisher","first-page":"19280","DOI":"10.1074\/jbc.M112.443010","volume":"288","author":"B Akhatib","year":"2013","unstructured":"Akhatib, B. et al. Chondroadherin fragmentation mediated by the protease HTRA1 distinguishes human intervertebral disc degeneration from normal aging. J. Biol. Chem. 288, 19280\u201319287 (2013).","journal-title":"J. Biol. Chem."},{"key":"243_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0925-4439(97)00032-X","volume":"1361","author":"LA Goldstein","year":"1997","unstructured":"Goldstein, L. A. et al. Molecular cloning of seprase: a serine integral membrane protease from human melanoma. Biochim. Biophys. Acta 1361, 11\u201319 (1997).","journal-title":"Biochim. Biophys. Acta"},{"key":"243_CR35","doi-asserted-by":"publisher","first-page":"36505","DOI":"10.1074\/jbc.274.51.36505","volume":"274","author":"JE Park","year":"1999","unstructured":"Park, J. E. et al. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J. Biol. Chem. 274, 36505\u201336512 (1999).","journal-title":"J. Biol. Chem."},{"key":"243_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/0-387-32824-6_18","volume":"575","author":"E Balaziova","year":"2006","unstructured":"Balaziova, E. et al. Dipeptidyl peptidase-IV activity and\/or structure homologs (DASH): contributing factors in the pathogenesis of rheumatic diseases? Adv. Exp. Med. Biol. 575, 169\u2013174 (2006).","journal-title":"Adv. Exp. Med. Biol."},{"key":"243_CR37","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/prca.201300095","volume":"8","author":"EJ Hamson","year":"2014","unstructured":"Hamson, E. J., Keane, F. M., Tholen, S., Schilling, O. & Gorrell, M. D. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. Proteom. Clin. Appl. 8, 454\u2013463 (2014).","journal-title":"Proteom. Clin. Appl."},{"key":"243_CR38","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1074\/jbc.M115.710582","volume":"291","author":"DR Dunshee","year":"2016","unstructured":"Dunshee, D. R. et al. Fibroblast activation protein cleaves and inactivates fibroblast growth factor 21. J. Biol. Chem. 291, 5986\u20135996 (2016).","journal-title":"J. Biol. Chem."},{"key":"243_CR39","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1182\/blood-2005-08-3452","volume":"107","author":"KN Lee","year":"2006","unstructured":"Lee, K. N. et al. Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein. Blood 107, 1397\u20131404 (2006).","journal-title":"Blood"},{"key":"243_CR40","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/j.1742-4658.2011.08051.x","volume":"278","author":"FM Keane","year":"2011","unstructured":"Keane, F. M., Nadvi, N. A., Yao, T. W. & Gorrell, M. D. Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-alpha. FEBS J. 278, 1316\u20131332 (2011).","journal-title":"FEBS J."},{"key":"243_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1074\/mcp.RA118.001046","volume":"18","author":"HE Zhang","year":"2019","unstructured":"Zhang, H. E. et al. Identification of novel natural substrates of fibroblast activation protein-alpha by differential degradomics and proteomics. Mol. Cell Proteom. 18, 65\u201385 (2019).","journal-title":"Mol. Cell Proteom."},{"key":"243_CR42","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1073\/pnas.91.12.5657","volume":"91","author":"MJ Scanlan","year":"1994","unstructured":"Scanlan, M. J. et al. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc. Natl. Acad. Sci. USA 91, 5657\u20135661 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"243_CR43","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1073\/pnas.85.9.3110","volume":"85","author":"WJ Rettig","year":"1988","unstructured":"Rettig, W. J. et al. Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc. Natl Acad. Sci. USA 85, 3110\u20133114 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"243_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.drup.2005.03.002","volume":"8","author":"T Kelly","year":"2005","unstructured":"Kelly, T. Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy. Drug Resist. Updat. 8, 51\u201358 (2005).","journal-title":"Drug Resist. Updat."},{"key":"243_CR45","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","volume":"87","author":"P Garin-Chesa","year":"1990","unstructured":"Garin-Chesa, P., Old, L. J. & Rettig, W. J. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc. Natl. Acad. Sci. USA 87, 7235\u20137239 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"243_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2013.12.010","volume":"25","author":"E Cortez","year":"2014","unstructured":"Cortez, E., Roswall, P. & Pietras, K. Functional subsets of mesenchymal cell types in the tumor microenvironment. Semin. Cancer Biol. 25, 3\u20139 (2014).","journal-title":"Semin. Cancer Biol."},{"key":"243_CR47","doi-asserted-by":"publisher","first-page":"eaai8524","DOI":"10.1126\/scitranslmed.aai8524","volume":"10","author":"X Kou","year":"2018","unstructured":"Kou, X. et al. The Fas\/Fap-1\/Cav-1 complex regulates IL-1RA secretion in mesenchymal stem cells to accelerate wound healing. Sci. Transl. Med. 10, eaai8524 (2018).","journal-title":"Sci. Transl. Med."},{"key":"243_CR48","doi-asserted-by":"publisher","first-page":"108252","DOI":"10.1016\/j.celrep.2020.108252","volume":"33","author":"H Wei","year":"2020","unstructured":"Wei, H. et al. Identification of fibroblast activation protein as an osteogenic suppressor and anti-osteoporosis drug target. Cell Rep. 33, 108252 (2020).","journal-title":"Cell Rep."},{"key":"243_CR49","doi-asserted-by":"publisher","first-page":"R171","DOI":"10.1186\/ar2080","volume":"8","author":"S Bauer","year":"2006","unstructured":"Bauer, S. et al. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res. Ther. 8, R171 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"243_CR50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13075-015-0524-6","volume":"17","author":"S Waldele","year":"2015","unstructured":"Waldele, S. et al. Deficiency of fibroblast activation protein alpha ameliorates cartilage destruction in inflammatory destructive arthritis. Arthritis Res. Ther. 17, 12 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"243_CR51","doi-asserted-by":"publisher","first-page":"7577","DOI":"10.1073\/pnas.94.14.7577","volume":"94","author":"A Hiraoka","year":"1997","unstructured":"Hiraoka, A. et al. Cloning, expression, and characterization of a cDNA encoding a novel human growth factor for primitive hematopoietic progenitor cells. Proc. Natl. Acad. Sci. USA 94, 7577\u20137582 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"243_CR52","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/sj.thj.6200118","volume":"2","author":"A Hiraoka","year":"2001","unstructured":"Hiraoka, A. et al. Stem cell growth factor: in situ hybridization analysis on the gene expression, molecular characterization and in vitro proliferative activity of a recombinant preparation on primitive hematopoietic progenitor cells. Hematol. J. 2, 307\u2013315 (2001).","journal-title":"Hematol. J."},{"key":"243_CR53","doi-asserted-by":"publisher","first-page":"e18782","DOI":"10.7554\/eLife.18782","volume":"5","author":"R Yue","year":"2016","unstructured":"Yue, R., Shen, B. & Morrison, S. J. Clec11a\/osteolectin is an osteogenic growth factor that promotes the maintenance of the adult skeleton. eLife 5, e18782 (2016).","journal-title":"eLife"},{"key":"243_CR54","doi-asserted-by":"publisher","first-page":"e42274","DOI":"10.7554\/eLife.42274","volume":"8","author":"B Shen","year":"2019","unstructured":"Shen, B. et al. Integrin alpha11 is an Osteolectin receptor and is required for the maintenance of adult skeletal bone mass. eLife 8, e42274 (2019).","journal-title":"eLife"},{"key":"243_CR55","doi-asserted-by":"publisher","first-page":"7437","DOI":"10.1074\/jbc.M511112200","volume":"281","author":"CY Edosada","year":"2006","unstructured":"Edosada, C. Y. et al. Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity. J. Biol. Chem. 281, 7437\u20137444 (2006).","journal-title":"J. Biol. Chem."},{"key":"243_CR56","first-page":"445","volume":"45","author":"J Niedermeyer","year":"2001","unstructured":"Niedermeyer, J. et al. Expression of the fibroblast activation protein during mouse embryo development. Int. J. Dev. Biol. 45, 445\u2013447 (2001).","journal-title":"Int. J. Dev. Biol."},{"key":"243_CR57","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nprot.2008.95","volume":"3","author":"M Gosset","year":"2008","unstructured":"Gosset, M., Berenbaum, F., Thirion, S. & Jacques, C. Primary culture and phenotyping of murine chondrocytes. Nat. Protoc. 3, 1253\u20131260 (2008).","journal-title":"Nat. Protoc."},{"key":"243_CR58","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/joca.1998.0219","volume":"7","author":"MB Goldring","year":"1999","unstructured":"Goldring, M. B. & Berenbaum, F. Human chondrocyte culture models for studying cyclooxygenase expression and prostaglandin regulation of collagen gene expression. Osteoarthr. Cartil. 7, 386\u2013388 (1999).","journal-title":"Osteoarthr. Cartil."},{"key":"243_CR59","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0945-053X(02)00007-0","volume":"21","author":"A Liacini","year":"2002","unstructured":"Liacini, A., Sylvester, J., Li, W. Q. & Zafarullah, M. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol. 21, 251\u2013262 (2002).","journal-title":"Matrix Biol."},{"key":"243_CR60","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1002\/1529-0131(200010)43:10<2189::AID-ANR6>3.0.CO;2-S","volume":"43","author":"JR Robbins","year":"2000","unstructured":"Robbins, J. R. et al. Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1beta. Arthritis Rheum.43, 2189\u20132201 (2000).","journal-title":"Arthritis Rheum."},{"key":"243_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-245","volume":"11","author":"HO Lee","year":"2011","unstructured":"Lee, H. O. et al. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells. BMC Cancer 11, 245 (2011).","journal-title":"BMC Cancer"},{"key":"243_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09790-1","volume":"7","author":"CK Nagaraju","year":"2017","unstructured":"Nagaraju, C. K. et al. Global fibroblast activation throughout the left ventricle but localized fibrosis after myocardial infarction. Sci. Rep. 7, 10801 (2017).","journal-title":"Sci. Rep."},{"key":"243_CR63","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1093\/eurheartj\/ehq519","volume":"32","author":"CE Brokopp","year":"2011","unstructured":"Brokopp, C. E. et al. Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata. Eur. Heart J. 32, 2713\u20132722 (2011).","journal-title":"Eur. Heart J."},{"key":"243_CR64","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.abb.2006.11.006","volume":"457","author":"VJ Christiansen","year":"2007","unstructured":"Christiansen, V. J., Jackson, K. W., Lee, K. N. & McKee, P. A. Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV. Arch. Biochem. Biophys. 457, 177\u2013186 (2007).","journal-title":"Arch. Biochem. Biophys."},{"key":"243_CR65","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.1074\/jbc.M115.701433","volume":"291","author":"MH Fan","year":"2016","unstructured":"Fan, M. H. et al. Fibroblast activation protein (FAP) accelerates collagen degradation and clearance from lungs in mice. J. Biol. Chem. 291, 8070\u20138089 (2016).","journal-title":"J. Biol. Chem."},{"key":"243_CR66","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.joca.2021.03.013","volume":"29","author":"K Kumagai","year":"2021","unstructured":"Kumagai, K. et al. Changes of synovial fluid biomarker levels after opening wedge high tibial osteotomy in patients with knee osteoarthritis. Osteoarthr. Cartil. 29, 1020\u20131028 (2021).","journal-title":"Osteoarthr. Cartil."},{"key":"243_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-020-3120-0","volume":"21","author":"L Li","year":"2020","unstructured":"Li, L. et al. Profiling of inflammatory mediators in the synovial fluid related to pain in knee osteoarthritis. BMC Musculoskelet. Disord. 21, 99 (2020).","journal-title":"BMC Musculoskelet. Disord."},{"key":"243_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bcp.2019.02.037","volume":"165","author":"WE Van Spil","year":"2019","unstructured":"Van Spil, W. E., Kubassova, O., Boesen, M., Bay-Jensen, A. C. & Mobasheri, A. Osteoarthritis phenotypes and novel therapeutic targets. Biochem. Pharm. 165, 41\u201348 (2019).","journal-title":"Biochem. Pharm."},{"key":"243_CR69","doi-asserted-by":"publisher","first-page":"7595","DOI":"10.1074\/jbc.272.12.7595","volume":"272","author":"ML Pineiro-Sanchez","year":"1997","unstructured":"Pineiro-Sanchez, M. L. et al. Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease. J. Biol. Chem. 272, 7595\u20137601 (1997).","journal-title":"J. Biol. Chem."},{"key":"243_CR70","doi-asserted-by":"publisher","first-page":"19441","DOI":"10.1074\/jbc.C500092200","volume":"280","author":"K Aertgeerts","year":"2005","unstructured":"Aertgeerts, K. et al. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha. J. Biol. Chem. 280, 19441\u201319444 (2005).","journal-title":"J. Biol. Chem."},{"key":"243_CR71","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41574-020-0399-8","volume":"16","author":"CF Deacon","year":"2020","unstructured":"Deacon, C. F. Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus. Nat. Rev. Endocrinol. 16, 642\u2013653 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"key":"243_CR72","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","volume":"570","author":"AP Croft","year":"2019","unstructured":"Croft, A. P. et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 570, 246\u2013251 (2019).","journal-title":"Nature"},{"key":"243_CR73","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1083\/jcb.118.1.203","volume":"118","author":"M Mets\u00e4ranta","year":"1992","unstructured":"Mets\u00e4ranta, M. et al. Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain. J. Cell Biol. 118, 203\u2013212 (1992).","journal-title":"J. Cell Biol."},{"key":"243_CR74","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1046\/j.1469-7580.1997.19020201.x","volume":"190","author":"M Rintala","year":"1997","unstructured":"Rintala, M., Mets\u00e4ranta, M., S\u00e4\u00e4m\u00e4nen, A. M., Vuorio, E. & R\u00f6nning, O. Abnormal craniofacial growth and early mandibular osteoarthritis in mice harbouring a mutant type II collagen transgene. J. Anat. 190, 201\u2013208 (1997).","journal-title":"J. Anat."},{"key":"243_CR75","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2741\/1817","volume":"11","author":"PS Burrage","year":"2006","unstructured":"Burrage, P. S., Mix, K. S. & Brinckerhoff, C. E. Matrix metalloproteinases: role in arthritis. Front. Biosci. 11, 529\u2013543 (2006).","journal-title":"Front. Biosci."},{"key":"243_CR76","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/bs.pmbts.2017.04.003","volume":"148","author":"J Liu","year":"2017","unstructured":"Liu, J. & Khalil, R. A. Matrix metalloproteinase inhibitors as investigational and therapeutic tools in unrestrained tissue remodeling and pathological disorders. Prog. Mol. Biol. Transl. Sci. 148, 355\u2013420 (2017).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"243_CR77","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1172\/JCI118357","volume":"96","author":"AP Hollander","year":"1995","unstructured":"Hollander, A. P. et al. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J. Clin. Investig. 96, 2859\u20132869 (1995).","journal-title":"J. Clin. Investig."},{"key":"243_CR78","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/ard.16.4.494","volume":"16","author":"JH Kellgren","year":"1957","unstructured":"Kellgren, J. H. & Lawrence, J. S. Radiological assessment of osteo-arthrosis. Ann. Rheum. Dis. 16, 494\u2013502 (1957).","journal-title":"Ann. Rheum. Dis."},{"key":"243_CR79","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","volume":"14","author":"KP Pritzker","year":"2006","unstructured":"Pritzker, K. P. et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr. Cartil. 14, 13\u201329 (2006).","journal-title":"Osteoarthr. Cartil."},{"key":"243_CR80","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2559.2006.02508.x","volume":"49","author":"V Krenn","year":"2006","unstructured":"Krenn, V. et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 49, 358\u2013364 (2006).","journal-title":"Histopathology"},{"key":"243_CR81","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/978-1-4939-1215-5_23","volume":"1194","author":"J Lorenz","year":"2014","unstructured":"Lorenz, J. & Gr\u00e4ssel, S. Experimental osteoarthritis models in mice. Methods Mol. Biol. 1194, 401\u2013419 (2014).","journal-title":"Methods Mol. Biol."},{"key":"243_CR82","doi-asserted-by":"publisher","first-page":"17946","DOI":"10.1002\/jcp.28427","volume":"234","author":"Z Yao","year":"2019","unstructured":"Yao, Z. et al. Reduced PDGF-AA in subchondral bone leads to articular cartilage degeneration after strenuous running. J. Cell. Physiol. 234, 17946\u201317958 (2019).","journal-title":"J. Cell. Physiol."}],"container-title":["Bone Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41413-022-00243-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-022-00243-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-022-00243-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T07:16:42Z","timestamp":1672903002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41413-022-00243-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,2]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["243"],"URL":"https:\/\/doi.org\/10.1038\/s41413-022-00243-8","relation":{},"ISSN":["2095-6231"],"issn-type":[{"value":"2095-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,2]]},"assertion":[{"value":"19 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.Y., A.F. and F.Y. have filed a provisional patent on the use of Fap inhibitors as anti-osteoarthritis drugs. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All human samples were collected in accordance with the ethical guidelines and protocols approved by the Ethics Committee of Shanghai East Hospital. Written informed consent was obtained from all patients before sample collection. All animal procedures were approved by the Tongji University Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"3"}}